Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...

Fintel reports that on January 27, 2025, Stifel upgraded their outlook for Portillo's (NasdaqGS:PTLO) from Hold to Buy.

Stifel Nicolaus analyst Stephen Willey maintained a Hold rating on Exelixis (EXEL – Research Report) today and set a price target of $30.00.

Stifel analysts reiterated a Buy rating on Bicara Therapeutics Inc (NASDAQ:BCAX), maintaining a $47.00 price target. Trading ...

Stifel analyst Chris O’Cull upgraded Portillo’s (PTLO) to Buy from Hold with a price target of $16, up from $13. The firm previously downgraded ...

In this Market Factors, we cover one strategist’s view that Monday’s market volatility is just the beginning. A BofA report ...

XPO Inc (XPO) stock saw a modest uptick, ending the day at $139.1 which represents a slight increase of $0.09 or 0.06% from the prior close of $139.01. The stock opened at $138.64 and touched a low of ...

Nextdecade Corp (NEXT) stock saw a modest uptick, ending the day at $8.51 which represents a slight increase of $0.02 or 0.24% from the prior close of $8.49. The stock opened at $8.47 and touched a ...

According to Stifel, the Meta partnership positions EssilorLuxottica at the forefront of the smart glasses revolution. The ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.

Brown & Brown Inc (BRO), Nucor Corp (NUE), W R Berkley Corp (WRB). On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in ...